Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Nov 11 - Nov 16
Key pathophysiologic mechanisms include: Mucosal barrier dysfunction: Impaired epithelial tight junctions allow bacterial translocation, triggering innate immune activation T-helper cell dysregulation: Predominantly Th1 and Th17 pathways drive chronic inflammation via TNF-, IL-12, IL-23 the basis for biologic therapy targets Transmural inflammation: Unlike UC (mucosal only), CD involves all layers: mucosa submucosa muscularis propria serosa Granuloma formation: Non-caseating granulomas are pathognomonic but present in only ~3050% of biopsies Fibrosis and stricture: Chronic inflammation activates myofibroblasts collagen deposition luminal narrowing obstructive symptoms Fistula formation: Transmural ulcers penetrate serosa form sinus tracts connect to adjacent bowel, bladder, vagina, or skin 7
The typical human equivalent dose works out to approximately 0.0016-0.004 mg per kilogram of body weight
Serving Size: 4 Milliliters (0.81 tsp)
Anti-inflammatory effect and improved microcirculation GHK-Cu reduces proinflammatory cytokine levels by interfering with the inflammatory signaling cascade, specifically by suppressing the activity of NF-B, a key protein responsible for triggering inflammatory responses in the body
US$ 22.03
US$ 23.44
US$ 23.56
US$ 21.34
US$ 24.88
US$ 24.03
US$ 21.33
US$ 24.74
US$ 24.22
US$ 22.39
US$ 24.10
